Laura Capolongo
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Cancer therapeutics and mechanisms 16
- DNA and Nucleic Acid Chemistry 3
- Oncology 14
- Cancer Treatment and Pharmacology 3
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- Maria Grandi (10 shared papers)Nicola Mongelli (9 shared papers)Paolo Cozzi (9 shared papers)Cristina Geroni (11 shared papers)Italo Beria (7 shared papers)Maurizio D’Incalci (4 shared papers)Enrico Pesenti (4 shared papers)Gabriella Pezzoni (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (7 papers)British Journal of Cancer (4 papers)Investigational New Drugs (2 papers)Cytometry (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Laura Capolongo
34 papers receiving 578 citations
Peers
Comparison fields: 5 of 61
- Toxicology 49
- Hematology 107
- Oncology 199
- Genetics 75
- Organic Chemistry 171
Countries citing papers authored by Laura Capolongo
This map shows the geographic impact of Laura Capolongo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Capolongo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Capolongo more than expected).
Fields of papers citing papers by Laura Capolongo
This network shows the impact of papers produced by Laura Capolongo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Capolongo. The network helps show where Laura Capolongo may publish in the future.
Co-authors
The 25 scholars most cited alongside Laura Capolongo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 60 | |
| 2 | 1994 | 58 | |
| 3 | 2015 | 50 | |
| 4 | 2007 | 44 | |
| 5 | 1990 | 37 | |
| 6 | 1991 | 36 | |
| 7 | 1987 | 35 | |
| 8 | 2009 | 31 | |
| 9 | 1997 | 30 | |
| 10 | 2000 | 28 | |
| 11 | Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a novel antineoplastic agent. | 2001 | 17 |
| 12 | 1997 | 17 | |
| 13 | 1996 | 16 | |
| 14 | Sequence-specific DNA alkylation of novel tallimustine derivatives. | 1998 | 15 |
| 15 | 1997 | 15 | |
| 16 | 1994 | 14 | |
| 17 | 2000 | 13 | |
| 18 | 1990 | 13 | |
| 19 | 1999 | 11 | |
| 20 | 1993 | 9 |
About Laura Capolongo
Laura Capolongo is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Hematology and Genetics, having authored 34 papers that have together received 599 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (16 papers), Synthesis and Biological Evaluation (7 papers), Cancer Treatment and Pharmacology (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Bioactive Compounds and Antitumor Agents (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), DNA and Nucleic Acid Chemistry (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Toxicology (49 citations), Hematology (107 citations), Oncology (199 citations), Genetics (75 citations) and Organic Chemistry (171 citations). Laura Capolongo has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Maria Grandi, Nicola Mongelli, Paolo Cozzi, Cristina Geroni, Italo Beria, Maurizio D’Incalci, Enrico Pesenti, Gabriella Pezzoni, Dario Ballinari and Marina Caldarelli. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, British Journal of Cancer, Investigational New Drugs, Cytometry and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.